Xcout IntelSign inSubscribe

Anika Therapeutics Inc.

ANIKMedical DevicesBedford, United States

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain management family, which includes established treatments like Monovisc, Orthovisc, Cingal, and Hyvisc, all designed to alleviate discomfort from osteoarthritis. The company's joint preservation and restoration offerings are extensive, comprising approximately 150 bone-sparing joint technology products, alongside solutions for sports medicine soft tissue repair and orthopedic regenerative therapies. Furthermore, Anika leverages its HA expertise in a non-orthopedic product family, developing applications such as adhesion barriers, advanced wound care products, ophthalmic solutions, and ear, nose, and throat treatments. Anika Therapeutics, Inc. was established in 1983 and is based in Bedford, Massachusetts.

Subscribe to see Anika Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Anika Therapeutics Inc. at a glance

Anika Therapeutics Inc. is a medical devices company headquartered in Bedford, United States. It is publicly listed (ANIK) with a market capitalisation of $287.3M. Xcout tracks 25 named people at Anika Therapeutics Inc., including Stephen D. Griffin (President, Principal Financial Officer, CEO & Director).

Industry
Medical Devices
Headquarters
Bedford, United States
Market cap
$287.3M
Employees
288
Ticker
ANIK

Anika Therapeutics Inc. leadership

  • Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director
  • Steve GriffinPresident and Chief Executive Officer
  • Ian W. McLeodSenior VP, Chief Accounting Officer & Treasurer
  • Ian McLeodSenior Vice President, Chief Accounting Officer and Treasurer
  • Lisa FunicielloVP & Chief Human Resources Officer
  • Cheryl Renee BlanchardExecutive Chair

19 more named people on record for Anika Therapeutics Inc., with roles, board committees and tenure — see the full roster →

Anika Therapeutics Inc. competitors

A few of Anika Therapeutics Inc.'s closest competitors — see the full list of competitors and alternatives →

Globus Medical, Inc.GMED · Medical DevicesAudubon, United States
67% matchPublic

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.

Market cap$10B
Employees5,300
Globus Medical, Inc. competitors & alternatives →
Axogen, Inc.AXGN · Medical DevicesAlachua, United States
67% matchPublicAI 30/100Green 3/100

AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating the gentle reconnection of severed peripheral nerves, the company offers the AxoGuard Nerve Connector, an extracellular matrix (ECM) derived from porcine submucosa. This same porcine submucosa ECM forms the basis of the AxoGuard Nerve Protector, which is utilized to encase and safeguard damaged peripheral nerves, supporting their reconstruction and preventing unwanted adhesions from surrounding soft tissues. Another ECM product, the AxoGuard Nerve Cap, isolates the nerve end from its environment to help mitigate the formation of painful neuromas. Furthermore, AxoGen provides the Avive Soft Tissue Membrane, a processed human umbilical cord membrane that functions as an absorbable covering for soft tissues, used to separate tissues within the surgical area. An additional tool available is the AxoTouch two-point discriminator, used for evaluating the density of nerve innervation on the skin's surface. These products are supplied to hospitals, surgery centers, and military medical facilities, catering to plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen's market reach extends across the United States, Canada, Germany, the United Kingdom, other European nations, South Korea, and internationally. The company's main operations are situated in Alachua, Florida.

Market cap$1.9B
Employees622
GCPSpring
Axogen, Inc. competitors & alternatives →

Get Anika Therapeutics Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Anika Therapeutics Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Anika Therapeutics Inc. in Xcout Intel

  • 25 named people with titles, LinkedIn and board committees
  • 2 corporate events with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →